| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,417 |
3,932 |
$220K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
318 |
290 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
449 |
407 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
807 |
704 |
$12K |
| 87428 |
|
56 |
56 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
77 |
75 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
50 |
48 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
70 |
70 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
32 |
30 |
$2K |
| 87634 |
|
13 |
12 |
$676.00 |
| 81002 |
|
249 |
230 |
$642.20 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
46 |
29 |
$510.02 |
| 87807 |
|
49 |
44 |
$492.94 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
55 |
40 |
$48.92 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
42 |
28 |
$3.74 |